The US AR/VR medical simulation market was valued at around $0.9 Bn in 2022 and is projected to reach $2.7 Bn in 2030, with a 15.3% CAGR. The major reasons propelling the growth of this market are the increasing use of AR/VR technology in healthcare, patient safety, the growing need for top-notch medical education, and the rise in government financing for medical simulation. The market is dominated by key players like OssoVR, Surgical Theater, and CAE Healthcare.
The US AR/VR medical simulation market was valued at around $0.9 Bn in 2022 and is projected to reach $2.7 Bn in 2030, with a 15.3% CAGR. The medical simulation market using AR/VR is growing continuously due to the advantages it has to offer such as the ability to create highly accurate simulations of clinical scenarios, an immersive and realistic training environment, increasing demand for minimally invasive procedures and natural interactions with virtual objects and environments. The US is by far the largest market, accounting for more than 40% of the worldwide medical simulation market
The US is one of the top adopters of AR/VR in healthcare and medical schools are increasingly using these technologies for providing medical training. VR-based training can improve the pass rate for tasks trained with VR by up to 31% compared to conventionally trained groups. For instance, the Johns Hopkins School of Nursing has been using VR training at all levels of training, including prelicensure and doctorate nursing. Resuscitation, allergic reactions, postsurgical management, acute-care management, and pediatric critical care are the major focus areas in VR training. The prime advantage of this training is the freedom it offers to practice an exercise multiple times which is not possible in the traditional cadaver or bio skills lab.
Market Growth Drivers
Market Restraints
Key Players
June 2023: A partnership was announced between SimX, a virtual reality (VR) medical simulation platform, and Laerdal Medical, a provider of simulation-based training in the areas of resuscitation, patient care, and emergency care training. This partnership has the potential to significantly contribute to the AR/VR medical simulation market in the US.
November 2022: Gaumard Scientific Co. introduced its cutting-edge patient simulator, HAL® S5301, at Emory University's Nell Hodgson Woodruff School of Nursing's advanced simulation and learning center. This marks the inaugural commercial deployment of HAL S5301, with shipments commencing across the US.
US Food and Drug Administration (FDA): Devices classified as medical devices and medical simulation software are governed by the Food and Drug Administration (FDA) in the US. Certain AR/VR applications may require FDA approval or authorization depending on their intended usage. This covers all applications directly related to patient care or treatment, as well as surgical simulators and diagnostic tools
Health Insurance Portability and Accountability Act (HIPAA): It governs the usage of patient data and private health information. All healthcare AR/VR applications must adhere to stringent data security and privacy regulations so as to preserve patient confidentiality
Clinical Laboratory Improvement Amendments (CLIA): Medical simulation-related clinical laboratories might have to adhere to CLIA regulations. This is especially true if they handle human specimens for training and diagnosis.
Accreditation Bodies: Medical simulation programs used in educational institutions and healthcare facilities need to follow the rules set by accrediting organizations such as the Commission on Accreditation of Healthcare Simulation Programs (CAHSP) and the Accreditation Council for Graduate Medical Education (ACGME).
Educational Accreditation: Accreditation requirements set by educational organizations such as the Commission on Collegiate Nursing Education (CCNE) for nursing programs and the Liaison Committee on Medical Education (LCME) for medical schools have to be followed by academic institutions involved in medical education using AR/VR technology.
1. Executive Summary
1.1 Digital Health Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Digital Health Policy in Country
1.6 Recent Developments in the Country
2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)
3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints
4. Competitive Landscape
4.1 Major Market Share
4.2 Key Company Profile (Check all Companies in the Summary Section)
4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)
5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment
6. Methodology and Scope
By Product and Service
By End-Users
By Application
Methodology for Database Creation
Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.
Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.
How Do We Get It?
Our database is created and maintained through a combination of secondary and primary research methodologies.
1. Secondary Research
With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:
With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:
2. Primary Research
To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:
Combining Secondary and Primary Research
By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:
Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.
We value your inquiry and offer free customization with every report to fulfil your exact research needs.